The European Medicines Agency (EMA)  released a draft guideline  for public consultation on the quality requirements for medical devices in human medicines that include a medical device, known as drug-device combinations. The guideline covers devices that are necessary for the administration, dosing or use of the medicine. They can be integral, co-packaged or referred to in the product information of the medicine but obtained separately. It is intended that this guideline will increase transparency and consistency of information in regulatory…